In a move to re-engineer the process of translating scientific discoveries into new drugs, diagnostics, and devices, the National Institutes of Health has established the National Center for Advancing Translational Sciences (NCATS). The action was made possible by Congress’ approval of a fiscal year 2012 spending bill and the president’s signing of the bill, which includes the establishment of NCATS with a budget of $575 million.
Some events are once-in-a-lifetime and just have to be observed. Here at Highlight HEALTH, we’re coming up on one of those events: our five year anniversary!
To celebrate this milestone and to give something back to our readers, for the next three months we’re holding a prize pack giveaway.
Alfred Nobel was a Swedish chemist, inventor, entrepreneur, author and pacifist . He was born on October 21st, 1833. After his death in 1896, much of his estate was used to establish the Nobel Prize. In 1993 on the 160th anniversary of Nobel’s birth, President Bill Clinton proclaimed October 21st as “National Biomedical Research Day” .
On National Biomedical Research Day, we celebrate the central role that biomedical research plays in improving human health and longevity. On this day, we acknowledge the promise that biomedical research plays for securing the future physical and mental well-being of people around the world. Biomedical research not only provides data that scientists and physicians need to treat and prevent diseases, but it also reveals the fundamental nature of life in humans, other animals, and plants.
The National Institutes of Health recently announced that it is awarding $143.8 million to challenge the status quo with innovative ideas that have the potential to propel fields forward and speed the translation of research into improved health for the American public.
These awards are granted under three innovative research programs supported by the NIH Common Fund: the NIH Director’s Pioneer, New Innovator, and Transformative Research Projects Awards. The Common Fund, enacted into law by Congress through the 2006 NIH Reform Act, supports trans-NIH programs with a particular emphasis on innovation and risk taking.
This Friday, the U.S. House appropriations subcommittee that determines funding for National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Agency for Healthcare Research and Quality (AHRQ) will make their funding recommendation for fiscal year 2012.
It is critically important that you urge your congressional members to fight for increased investment in medical research in FY 2012 (link below). Here’s why: biomedical research and the biotechnology industry is a major driver of the U.S. economy and has been for the past 30 years . Despite budgetary constraints, America cannot afford to fall behind when it comes to investing in biomedical research and America’s future. These investments are crucial to overcome the health challenges facing our nation and to create the jobs that will help revitalize our economy.